Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Abiomed, Inc.

Abiomed, Inc. (ABMD) Stock Overview

Explore Abiomed, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ABMD●NASDAQ
HealthcareMedical - Devices
$381.02
$0.00(0.00%)
U.S. Market opens in 3h 2m

Abiomed, Inc. (ABMD)

Meyka AI Score

Z

Key Financials

Market Cap17.2B
P/E Ratio127.01
EPS (TTM)$5.83
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

ABMD Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Abiomed, Inc. (NASDAQ: ABMD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Abiomed, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ABMD on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Abiomed, Inc.'s NASDAQ-traded stock include a P/E ratio of 127.01 and a market capitalization of 17.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ABMD on the NASDAQ.

Price Performance (NASDAQ: ABMD)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
1.88%
6-Month Change
29.78%
Year-to-Date (YTD) Change
N/A
1-Year Change
31.19%
3-Year Change
128.24%
5-Year Change
63.02%
All-Time (Max) Change
6827.64%

Contact Information

https://www.heartrecovery.com
19787775410
22 CHERRY HILL DR, Danvers, MA, 01923

Company Facts

20,030 Employees
IPO DateJul 29, 1987
CountryUS

Frequently Asked Questions